Abstract:Chemodynamic therapy (CDT) is an emerging cancer treatment strategy that uses CDT agents to convert hydrogen peroxide (H2O2) into the hydroxyl radical (OH), the most harmful reactive oxygen species (ROS) by the Fenton/Fenton-like reactions, thus inducing cell apoptosis and necrosis. This treatment method has been widely studied because of its minimal invasiveness and high tumor specificity, and has become a popular topic of research. Despite the great potential of CDT in tumor treatment, the clinical conversion of CDT is still facing challenges: 1) the relatively high pH of the tumor sites is not suitable for the occurrence of most Fenton/Fenton-like reactions; 2) the low concentration of endogenous H2O2 at the tumors is not enough to generate continuous ROS such as OH; and 3) the high expression of reducing substances (e.g., glutathione, GSH) in the tumor microenvironment (TME) weakens the therapeutic effect of CDT. These limitations make it difficult for CDT alone to completely eliminate malignant tumors. Therefore, CDT-based combined treatment strategies have been widely developed. CDT-based combined therapy refers to the combination of CDT and other cancer treatments (e.g., photo-induced therapy, chemotherapy, sonodynamic therapy, starvation therapy, and gas therapy), which can produce a synergistic anticancer effect. This combined therapy can reduce individual drug-related toxicity and significantly enhance therapeutic efficiency, which has recently seen rapid development. This review begins by defining CDT, then it identifies the problems faced in CDT and proposes various strategies to enhance CDT performance, primarily focusing on CDT-based combined cancer treatment. The problems, opportunities, and challenges of CDT-based combination cancer therapy are also summarized, thereby providing a reference for the future development of CDT-based combined therapy.

Comprehensively Optimizing Fenton Reaction Factors for Antitumor Chemodynamic Therapy by Charge-Reversal Theranostics

Chemodynamic Therapy: Integration of Fenton Chemistry and Biomedicine

Recent advances in enhancing reactive oxygen species based chemodynamic therapy

Recent advances in augmenting Fenton chemistry of nanoplatforms for enhanced chemodynamic therapy

Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions

Current Progress on the Regulation of Endogenous Molecules for Enhanced Chemodynamic Therapy

Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment

Development of an Intelligent Heterojunction Fenton Catalyst for Chemodynamic/starvation Synergistic Cancer Therapy

Recent advances in enhanced chemodynamic therapy strategies

Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer

Emerging Chemodynamic Nanotherapeutics for Cancer Treatment

Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy

Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions

Nanocatalyst‐Mediated Chemodynamic Tumor Therapy

Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy

Boosting Chemodynamic Therapy by the Synergistic Effect of Co-Catalyze and Photothermal Effect Triggered by the Second Near-Infrared Light

A versatile supramolecular nanoagent for three-pronged boosting chemodynamic therapy

Recent progress of chemodynamic therapy-induced combination cancer therapy

Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation

pH-responsive iron-loaded carbonaceous nanoparticles for chemodynamic therapy based on the Fenton reaction

Active-transporting of charge-reversal Cu(II)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy